Evaluating TENEX for hip pain relief
Evaluation of Percutaneous Tenotomy of the Gluteus Medius and Iliotibial Band for Greater Trochanteric Pain Syndrome (GTPS): A Randomized Clinical Trial
NA · Montefiore Medical Center · NCT05710627
This study is testing if a special ultrasound-guided procedure called TENEX can help people with chronic hip pain feel better and move easier when other treatments haven't worked.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 30 Years to 90 Years |
| Sex | All |
| Sponsor | Montefiore Medical Center (other) |
| Locations | 1 site (The Bronx, New York) |
| Trial ID | NCT05710627 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an ultrasound-guided procedure called TENEX for treating chronic hip pain caused by Greater Trochanteric Pain Syndrome (GTPS). The procedure involves a partial release of the gluteus medius and minimus tendons, as well as the Iliotibial band, in patients who have not responded to conservative treatments for at least six months. The goal is to reduce pain, improve mobility, and decrease the need for medication, thereby enhancing patients' ability to perform daily activities. The study will compare outcomes between those receiving the TENEX treatment and a control group.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-90 with confirmed GTPS who have not improved after at least six months of conservative medical management.
Not a fit: Patients with significant mobility restrictions, those who are pregnant, or individuals who have had previous surgery on the affected tendons may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve mobility for patients suffering from GTPS.
How similar studies have performed: Previous studies have shown promising results with similar approaches, indicating a potential for significant improvement in pain management for GTPS.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18-90 * People with GTPS of all different levels and etiologies confirmed with MRI or CT scan * Ability to give informed consent forms independently * Failed conservative medical treatment for at least 6 months Exclusion Criteria: * Significant mobility restrictions; people using wheelchairs * Pregnancy * Previous surgery to the GMed or ITB
Where this trial is running
The Bronx, New York
- Montefiore Medical Center — The Bronx, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Sayed E. Wahezi, MD — Montefiore Medical Center
- Study coordinator: Tahereh Naeimi, MD
- Email: tnaeimi@montefiore.org
- Phone: 3479778678
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Greater Trochanteric Pain Syndrome